A comparison of two methods for measurement of von Willebrand's factor (ristocetin cofactor)
Dowling, S.V.; Ekert, H.
Thrombosis and Haemostasis 36(1): 284-285
1976
ISSN/ISBN: 0340-6245 PMID: 1087476 Document Number: 97257
Document emailed within 1 workday
Related Documents
Chang, P.; Aronson, D.L. 1997: Plasma derived von Willebrand factor preparations: collagen binding and ristocetin cofactor activities Thrombosis and Haemostasis 78(2): 930-933Veyradier, A.; Fressinaud, E.; Boyer-Neumann, C.; Trossaert, M.; Meyer, D. 2000: Von Willebrand factor ristocetin cofactor activity correlates with platelet function in a high shear stress system Thrombosis and Haemostasis 84(4): 727-728
Federici, A.B.; Canciani, M.T.; Forza, I.; Cozzi, G. 2000: Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease--single center comparison of four different assays Thrombosis and Haemostasis 84(6): 1127-1128
Takahashi, H. 1981: Studies on the pathophysiology and treatment of von Willebrand's disease. III. Binding of plasma factor VIIi to platelets in the presence of ristocetin Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(4): 910-920
Olson, J.D.; Zaleski, A.; Herrmann, D.; Flood, P.A. 1989: Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin Journal of Laboratory and Clinical Medicine 114(1): 6-18
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Woods, A.I.; Sutton, N.M.; Kempfer, A.C.; Casillas, G.; Lazzari, M.A. 1985: Use of ultrasonicated plasma as a diluent in the technic for measuring ristocetin cofactor Sangre 30(6): 999-1006
Kitchen, S.; Malia, R.G.; Preston, F.E. 1992: A comparison of methods for the measurement of activated factor VII Thrombosis and Haemostasis 68(3): 301-305
Iwata, K.; Seya, T.; Ariga, H.; Nagasawa, S. 1994: Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein Journal of Immunology 152(7): 3436-3444
Akai, Y.; Shiga, S.; Tohyama, K.; Shimatsu, A.; Ichiyama, S. 2000: Effect of heparin cofactor Ii on the antithrombin IIi activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women Rinsho Byori. Japanese Journal of Clinical Pathology 48(9): 867-871
Mahajan, K.K.; Mahajan, A.; Mishra, N. 1996: Comparison of single breath and steady state methods for measurement of lung transfer factor for CO in normal subjects and smokers Indian Journal of Physiology and Pharmacology 40(3): 267-270
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Lu, G-yuan.; Shen, L.; Wang, Z-yue.; Guo, X-fang.; Bai, X.; Su, J.; Ruan, C-geng. 2008: Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chinese Medical Journal 121(2): 133-136
Girma, J.P.; Pietu, G.; Lavergne, J.M.; Meyer, D.; Larrieu, M.J. 1982: Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease Journal of Laboratory and Clinical Medicine 99(4): 481-494
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Moser, J.; Meyers, K.M.; Meinkoth, J.H.; Brassard, J.A. 1996: Temporal variation and factors affecting measurement of canine von Willebrand factor American Journal of Veterinary Research 57(9): 1288-1293
Meyer, D.; Obert, B.; Pietu, G.; Lavergne, J.M.; Zimmerman, T.S. 1980: Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease Journal of Laboratory and Clinical Medicine 95(4): 590-602
Wright, R.D.; Krauss, J.S. 1990: A comparison of two macroscopic platelet agglutination assays for von Willebrand factor Annals of Clinical and Laboratory Science 20(1): 73-78
Jurina, K.; Gropp, F.; Oechtering, G. 1996: The determination of von Willebrand factor activity in the plasma of dogs. 1. Experimental evaluation and methods Tierarztliche Praxis 24(6): 616-620
Fukui, H.; Okuda, T.; Takase, T.; Mikami, S.; Yoshioka, A.; Fujimura, Y.; Yoshioka, K. 1978: Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(5): 897-907